111 Revenue 2018-2024 | YI
111 revenue from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| 111 Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,973 |
| 2023 | $2,105 |
| 2022 | $1,960 |
| 2021 | $1,950 |
| 2020 | $1,257 |
| 2019 | $568 |
| 2018 | $260 |
| 2017 | $145 |
| 111 Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-12-31 | $500 |
| 2024-09-30 | $513 |
| 2024-06-30 | $471 |
| 2024-03-31 | $489 |
| 2023-12-31 | $585 |
| 2023-09-30 | $502 |
| 2023-06-30 | $480 |
| 2023-03-31 | $538 |
| 2022-12-31 | $565 |
| 2022-09-30 | $471 |
| 2022-06-30 | $453 |
| 2022-03-31 | $470 |
| 2021-12-31 | $566 |
| 2021-09-30 | $519 |
| 2021-06-30 | $468 |
| 2021-03-31 | $396 |
| 2020-12-31 | $457 |
| 2020-09-30 | $348 |
| 2020-06-30 | $230 |
| 2020-03-31 | $223 |
| 2019-12-31 | $193 |
| 2019-09-30 | $155 |
| 2019-06-30 | $122 |
| 2019-03-31 | $98 |
| 2018-09-30 | $72 |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.070B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.557B | 53.26 |
| Tempus AI (TEM) | United States | $9.312B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.304B | 97.39 |
| Inspire Medical Systems (INSP) | United States | $4.724B | 73.15 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Privia Health (PRVA) | United States | $2.788B | 208.91 |
| Enovis (ENOV) | United States | $1.951B | 12.07 |
| Schrodinger (SDGR) | United States | $1.898B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.483B | 0.00 |
| Omnicell (OMCL) | United States | $1.428B | 30.80 |
| Azenta (AZTA) | United States | $1.197B | 55.74 |
| 10x Genomics (TXG) | United States | $1.053B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.539B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 313.00 |
| Veradigm (MDRX) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.393B | 0.00 |
| Claritev (CTEV) | United States | $0.346B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.221B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| Pulmonx (LUNG) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.083B | 0.00 |
| CareCloud (CCLD) | United States | $0.074B | 3.18 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |